ECD for Adult Liver Transplantation



Since Starzl performed the world’s first deceased-donor liver transplant in 1963, more than 6,000 deceased-donor liver transplants have been performed annually in the USA. There, as in other parts of the world, the biggest problem with liver transplants is the unequivocal shortage of donors. In response, countries mostly in Europe and the USA have explored extended criteria donors (ECD), which include elderly donors and donors with a fatty liver. This paper describes the current state of and problems with these ECD.


Liver Transplant Elderly Donor Cold Ischemia Time Primary Graft Dysfunction Macrovesicular Steatosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–76. PubMed PMID: 14100514. Pubmed Central PMCID: 2634660. Epub 1963/12/01. eng.PubMedCentralPubMedGoogle Scholar
  2. 2.
    Mehrabi A, Fonouni H, Muller SA, Schmidt J. Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg. 2008;393(3):245–60. PubMed PMID: 18309513. Epub 2008/03/01. eng.PubMedCrossRefGoogle Scholar
  3. 3.
    Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, et al. Combination of extended donor criteria and changes in the model for end-stage liver disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation. 2007;83(5):588–92. PubMed PMID: 17353779. Epub 2007/03/14. eng.PubMedCrossRefGoogle Scholar
  4. 4.
    Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation. 2006;82(12):1653–7. PubMed PMID: 17198254. Epub 2007/01/02. eng.PubMedCrossRefGoogle Scholar
  5. 5.
    Furukawa H, Taniguchi M, Fujiyoshi M, Oota M, Japanese Study Group of Liver T. Experience using extended criteria donors in first 100 cases of deceased donor liver transplantation in Japan. Transplant Proc. 2012;44(2):373–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Grazi GL, Cescon M, Ravaioli M, Ercolani G, Pierangeli F, D'Errico A, et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant. 2001;1(1):61–8. PubMed PMID: 12095041. Epub 2002/07/04. eng.PubMedCrossRefGoogle Scholar
  7. 7.
    Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl. 2003;9(5):500–5. PubMed PMID: 12740794. Epub 2003/05/13. eng.PubMedCrossRefGoogle Scholar
  8. 8.
    Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant. 2003;3(10):1259–63. PubMed PMID: 14510699. Epub 2003/09/27. eng.PubMedCrossRefGoogle Scholar
  9. 9.
    Cuende N, Grande L, Sanjuan F, Cuervas-Mons V. Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. Transplantation. 2002;73(8):1360. PubMed PMID: 11981439. Epub 2002/05/01. eng.PubMedCrossRefGoogle Scholar
  10. 10.
    Grande L, Rull A, Rimola A, Garcia-Valdecasas JC, Manyalic M, Cabrer C, et al. Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc. 1997;29(8):3289–90. PubMed PMID: 9414718. Epub 1998/01/01. eng.PubMedCrossRefGoogle Scholar
  11. 11.
    Imber CJ, St Peter SD, Handa A, Friend PJ. Hepatic steatosis and its relationship to transplantation. Liver Transpl. 2002;8(5):415–23. PubMed PMID: 12004340. Epub 2002/05/11. eng.PubMedCrossRefGoogle Scholar
  12. 12.
    Urena MA, Moreno Gonzalez E, Romero CJ, Ruiz-Delgado FC, Moreno SC. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology. 1999;46(26):1164–73. PubMed PMID: 10370686. Epub 1999/06/17. eng.PubMedGoogle Scholar
  13. 13.
    Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64(2):248–51. PubMed PMID: 9256182. Epub 1997/07/27. eng.PubMedCrossRefGoogle Scholar
  14. 14.
    Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21(1):105–13. PubMed PMID: 11296690. Epub 2001/04/12. eng.PubMedCrossRefGoogle Scholar
  15. 15.
    Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994;20(4 Pt 1):829–38. PubMed PMID: 7927223. Epub 1994/10/01. eng.PubMedCrossRefGoogle Scholar
  16. 16.
    Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant. 2004;4(5):686–93. PubMed PMID: 15084161. Epub 2004/04/16. eng.PubMedCrossRefGoogle Scholar
  17. 17.
    Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl. 2001;7(1):51–8. PubMed PMID: 11150423. Epub 2001/01/11. eng.PubMedCrossRefGoogle Scholar
  18. 18.
    Nery JR, Nery-Avila C, Reddy KR, Cirocco R, Weppler D, Levi DM, et al. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation. 2003;75(8):1179–86. PubMed PMID: 12717200. Epub 2003/04/30. eng.PubMedCrossRefGoogle Scholar
  19. 19.
    Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg. 2001;234(3):384–93. discussion 93–4. PubMed PMID: 11524591. Pubmed Central PMCID: 1422029. Epub 2001/08/29. eng.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl. 2001;7(9):762–8. PubMed PMID: 11552208. Epub 2001/09/12. eng.PubMedCrossRefGoogle Scholar
  21. 21.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl. 2006;12(10):1496–503. PubMed PMID: 16964597. Epub 2006/09/12. eng.PubMedCrossRefGoogle Scholar
  22. 22.
    Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999;117(1):149–53. PubMed PMID: 10381921. Epub 1999/06/26. eng.PubMedCrossRefGoogle Scholar
  23. 23.
    Barshes NR, Horwitz IB, Franzini L, Vierling JM, Goss JA. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant. 2007;7(5):1265–70. PubMed PMID: 17359503. Epub 2007/03/16. eng.PubMedCrossRefGoogle Scholar
  24. 24.
    Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006;243(6):748–53. discussion 53–5. PubMed PMID: 16772778. Pubmed Central PMCID: 1570573. Epub 2006/06/15. eng.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Briceno J, Ciria R, de la Mata M, Rufian S, Lopez-Cillero P. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Transplantation. 2010;90(5):530–9. PubMed PMID: 20581766. Epub 2010/06/29. eng.PubMedCrossRefGoogle Scholar
  26. 26.
    Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–90. PubMed PMID: 16539636. Epub 2006/03/17. eng.PubMedCrossRefGoogle Scholar
  27. 27.
    Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant. 2008;8(2):419–25. PubMed PMID: 18190658. Epub 2008/01/15. eng.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Division of Gastroenterologic and General Surgery, Department of SurgeryAsahikawa Medical UniversityAsahikawaJapan

Personalised recommendations